Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist (Q43270612)
Jump to navigation
Jump to search
scientific article published in October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist |
scientific article published in October 2009 |
Statements
1 reference
Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist (English)
1 reference
Carol Addy
1 reference
Patricia Jumes
1 reference
Kimberly Rosko
1 reference
Susie Li
1 reference
Hankun Li
1 reference
Andrea Maes
1 reference
Amy O Johnson-Levonas
1 reference
Jeffrey Chodakewitz
1 reference
S Aubrey Stoch
1 reference
John A Wagner
1 reference
1 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference